4.3 Article

Cytokine expression and cytokine-based T cell profiling in South Indian rheumatoid arthritis

Journal

IMMUNOBIOLOGY
Volume 219, Issue 10, Pages 772-777

Publisher

ELSEVIER GMBH
DOI: 10.1016/j.imbio.2014.06.004

Keywords

Cytokines; Rheumatoid arthritis; Th-1/Th-2/Th-17; Transcription factors

Categories

Funding

  1. ICMR-INSERM
  2. Assistance Publique des Hopitaux de Paris (AP-HP), Hopital Saint Louis, Paris, France [INDO/FRC/604/08-08, 50/9/2008/BMS]

Ask authors/readers for more resources

Rheumatoid arthritis (RA), a chronic inflammatory disease affects up to 1% of the general population. Early diagnosis and treatment are limited by the absence of specific and reliable diagnostic/prognostic biomarkers. This study was carried out in 48 Tamil South Indian RA patients and 49 healthy controls (HC) to identify any cytokine signature(s) that could potentially serve as biomarkers. Expression profiles of Th-1, Th-2, Th-17 and Tregs cell type-specifying cytokines and transcription factors were analyzed using real time quantitative PCR (qPCR) assay. To explore if such expression profiles mirror their steady state plasma levels, a bead-based multiplex fluorescent assay was carried out. We found that the expression of transcription factors T-bet (for Th-1), GATA-3 (for Th-2) and FoxP3 (for Tregs) were significantly lower in patients than in healthy controls (P <0.0001) similar to lowering of IFN gamma (P=0.004) and IL-10 (P=0.04). The transcript levels of IL-12p40 and TNF-alpha were higher among patients as compared to HC (P<0.0001 and P= 0.02, respectively). Circulating levels of assessed cytokines were in general higher in RA patients as compared to controls. These alterations in the expression of transcription factors and cytokines highlight the underlying dysregulation of T cell subsets in RA that reflects a predominantly inflammatory phenotype. Despite dissecting these cellular and molecular processes, no specific signature that could be of diagnostic and/or prognostic value was identified. Additional longitudinal follow-up studies,,especially on newly diagnosed treatment-naive patients are warranted to uncover clinically useful biomarkers of (C) 2014 Elsevier GmbH. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.3
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available